Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 543654 | NSE: MEDANTA

Global Health Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 21, 2024, 8:31 pm

Market Cap 28,963 Cr.
Current Price 1,073
High / Low1,514/872
Stock P/E59.4
Book Value 117
Dividend Yield0.00 %
ROCE19.3 %
ROE17.9 %
Face Value 2.00
PEG Ratio2.34

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Global Health Ltd

Competitors of Global Health Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Nalin Lease Finance Ltd 46.8 Cr. 71.399.9/33.711.7 51.10.00 %17.4 %13.1 % 10.0
India Cements Capital Ltd 39.1 Cr. 18.026.4/11.243.9 8.430.00 %3.50 %8.87 % 10.0
Indergiri Finance Ltd 17.5 Cr. 34.5110/33.5 8.260.00 %7.67 %14.0 % 10.0
Fedders Holding Ltd 1,332 Cr. 77.9130/48.016.4 36.20.00 %21.1 %22.5 % 1.00
Hybrid Financial Services Ltd 37.1 Cr. 12.715.8/7.7510.0 14.30.00 %7.93 %7.57 % 5.00
Industry Average20,516.00 Cr681.1532.74584.550.18%20.11%10.34%8.69

All Competitor Stocks of Global Health Ltd

Quarterly Result

MonthJun 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales485583521617679694707780844836809861
Expenses386448441485522534540595631620629675
Operating Profit10013680133157160167184213216179186
OPM %21%23%15%21%23%23%24%24%25%26%22%22%
Other Income6101291612251521182722
Interest161828191821201820181818
Depreciation313335363739384043444547
Profit before tax58952987117112133141171172143144
Tax %28%26%40%33%27%28%24%28%27%28%11%26%
Net Profit427018598681101102125124127106
EPS in Rs8.392.760.692.323.383.013.773.804.664.614.743.96

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales1,3821,3431,4561,5001,4472,1672,6943,2753,350
Expenses1,0811,2181,2831,3091,2501,7092,0732,4762,556
Operating Profit301125172192197458621799794
OPM %22%9%12%13%14%21%23%24%24%
Other Income454950443139647588
Interest142838577386867474
Depreciation7086102115123130150173179
Profit before tax26260836432281449627630
Tax %35%45%38%43%11%30%27%24%
Net Profit17033513629196326478482
EPS in Rs35.106.7810.447.365.817.7512.1617.8117.97
Dividend Payout %0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)54.55%-29.41%-19.44%575.86%66.33%46.63%
Change in YoY Net Profit Growth (%)0.00%-83.96%9.97%595.31%-509.54%-19.70%

Global Health Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:18%
3 Years:31%
TTM:14%
Compounded Profit Growth
10 Years:%
5 Years:56%
3 Years:155%
TTM:19%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:19%
Return on Equity
10 Years:%
5 Years:12%
3 Years:16%
Last Year:18%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

MonthMar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital4848494950515454
Reserves9761,1361,2461,3001,3331,5652,3752,852
Borrowings1654567879299311,1091,122802
Other Liabilities295343347388380421547597
Total Liabilities1,4851,9842,4302,6662,6943,1464,0974,304
Fixed Assets9141,0941,1941,7031,6161,7762,0502,237
CWIP12317666382464439327386
Investments00000000
Other Assets5595735705816159301,7201,681
Total Assets1,4851,9842,4302,6662,6943,1464,0974,304

Reserves and Borrowings Chart

Cash Flow

MonthMar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +22863166175242311645612
Cash from Investing Activity +-241-69-249-87-239-421-342-441
Cash from Financing Activity +-7997-1-81160346-514
Net Cash Flow-2031487-7850648-343

Free Cash Flow

MonthMar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow136.00-331.00-615.00-737.00-734.00457.00620.00-3.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days2041413634302624
Inventory Days2826264342363532
Days Payable921241421471389011490
Cash Conversion Cycle-45-56-75-67-62-24-52-34
Working Capital Days-23-15-11-22-22-2-18-13
ROCE %6%6%5%15%17%19%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters33.08%33.08%33.07%33.06%33.05%33.04%33.04%33.04%
FIIs9.36%9.89%10.58%10.69%11.36%12.10%12.94%12.21%
DIIs12.55%12.34%10.79%10.93%11.15%10.25%10.57%11.11%
Public45.01%44.67%45.55%45.31%44.45%44.60%43.44%43.64%
No. of Shareholders1,21,4071,07,1201,09,7981,16,6271,24,7751,66,2531,55,3071,49,722

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.0010.0010.00
Basic EPS (Rs.)17.8012.587.781.157.26
Diluted EPS (Rs.)17.8012.577.771.147.22
Cash EPS (Rs.)24.2417.7512.8730.6630.55
Book Value[Excl.RevalReserv]/Share (Rs.)108.2190.5463.82272.22266.90
Book Value[Incl.RevalReserv]/Share (Rs.)108.2190.5463.82272.22266.90
Revenue From Operations / Share (Rs.)121.98100.4685.56291.76300.78
PBDIT / Share (Rs.)32.5425.2519.3444.9446.58
PBIT / Share (Rs.)26.1119.6614.2220.0923.39
PBT / Share (Rs.)23.3616.7511.086.5512.95
Net Profit / Share (Rs.)17.8012.167.755.817.37
NP After MI And SOA / Share (Rs.)17.8112.167.755.817.36
PBDIT Margin (%)26.6725.1322.6015.4015.48
PBIT Margin (%)21.4019.5616.616.887.77
PBT Margin (%)19.1416.6712.942.244.30
Net Profit Margin (%)14.5912.109.051.992.44
NP After MI And SOA Margin (%)14.6012.109.051.992.44
Return on Networth / Equity (%)16.4513.4212.142.132.75
Return on Capital Employeed (%)19.0114.8713.204.355.01
Return On Assets (%)11.117.926.231.061.37
Long Term Debt / Equity (X)0.090.300.470.420.45
Total Debt / Equity (X)0.140.340.510.470.45
Asset Turnover Ratio (%)0.770.610.690.520.69
Current Ratio (X)2.442.761.941.241.38
Quick Ratio (X)2.332.651.811.141.27
Inventory Turnover Ratio (X)10.819.0010.588.4111.49
Interest Coverage Ratio (X)11.828.696.163.324.46
Interest Coverage Ratio (Post Tax) (X)7.475.183.471.431.71
Enterprise Value (Cr.)34786.0313675.200.000.000.00
EV / Net Operating Revenue (X)10.625.080.000.000.00
EV / EBITDA (X)39.8120.200.000.000.00
MarketCap / Net Operating Revenue (X)10.855.240.000.000.00
Price / BV (X)12.235.810.000.000.00
Price / Net Operating Revenue (X)10.855.240.000.000.00
EarningsYield0.010.020.000.000.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Global Health Ltd as of November 22, 2024 is: 1,268.89

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 22, 2024, Global Health Ltd is Undervalued by 18.26% compared to the current share price 1,073.00

Intrinsic Value of Global Health Ltd as of November 22, 2024 is: 1,590.37

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 22, 2024, Global Health Ltd is Undervalued by 48.22% compared to the current share price 1,073.00

Last 5 Year EPS CAGR: 25.34%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -15.75, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -51.88, which is a positive sign.
  3. The company has higher reserves (1,597.88 cr) compared to borrowings (787.63 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (1.67 cr) and profit (276.44 cr) over the years.
  1. The stock has a low average ROCE of 8.50%, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Global Health Ltd:
    1. Net Profit Margin: 14.59%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 19.01% (Industry Average ROCE: 20.11%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 16.45% (Industry Average ROE: 10.34%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 7.47
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.33
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 59.4 (Industry average Stock P/E: 32.74)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.14
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Global Capital Markets Ltd. is a Public Limited Listed company incorporated on 20/02/1989 and has its registered office in the State of West Bengal, India. Company’s Corporate Identification Number(CIN) is L51109WB1989PLC046292 and registration number is 046292. Currently Company is involved in the business activities of Administration of financial markets. Company’s Total Operating Revenue is Rs. 4.39 Cr. and Equity Capital is Rs. 24.89 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Non-Banking Financial Company (NBFC)Sir RNM House, Kolkata West Bengal 700001gcmil1995@gmail.com
http://www.globalcapitalmarketandinfraltd.co.in
Management
NamePosition Held
Mr. Inder Chand BaidChairman & Managing Director
Mr. Mahavir Prasad SaraswatIndependent Director
Mr. Urmi BoseIndependent Director
Mr. Laxmi Narayan SharmaIndependent Director

FAQ

What is the latest intrinsic value of Global Health Ltd?

The latest intrinsic value of Global Health Ltd as on 22 November 2024 is ₹1268.89, which is 18.26% higher than the current market price of ₹1,073.00.

What is the Market Cap of Global Health Ltd?

The Market Cap of Global Health Ltd is 28,963 Cr..

What is the current Stock Price of Global Health Ltd as on 22 November 2024?

The current stock price of Global Health Ltd as on 22 November 2024 is ₹1,073.

What is the High / Low of Global Health Ltd stocks in FY 2024?

In FY 2024, the High / Low of Global Health Ltd stocks is 1,514/872.

What is the Stock P/E of Global Health Ltd?

The Stock P/E of Global Health Ltd is 59.4.

What is the Book Value of Global Health Ltd?

The Book Value of Global Health Ltd is 117.

What is the Dividend Yield of Global Health Ltd?

The Dividend Yield of Global Health Ltd is 0.00 %.

What is the ROCE of Global Health Ltd?

The ROCE of Global Health Ltd is 19.3 %.

What is the ROE of Global Health Ltd?

The ROE of Global Health Ltd is 17.9 %.

What is the Face Value of Global Health Ltd?

The Face Value of Global Health Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Global Health Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE